Statement
From the Marijuana Policy Project Regarding Reports That Congressman Tom Marino
Will Be Named Next White House Drug Czar
WASHINGTON - April 12, 2017
(Investorideas.com Newswire) The Marijuana Policy Project has issued the
statement below in response to reports that Congressman Tom Marino (R-PA) will
be named the next director of the White House Office of National Drug Control
Policy (ONDCP), also known as the "drug czar."
As a member of Congress, Marino has
consistently voted against marijuana policy reform legislation.
Statement from Robert Capecchi,
director of federal policies for the Marijuana Policy Project:
"We are disappointed but not at
all surprised to hear a marijuana prohibitionist is being selected as the next
drug czar. After all, whoever fills the position is required by law to oppose
any attempts to legalize the use of marijuana for any purpose.
"Despite a steady stream of
anti-marijuana drug czars over the past several decades, 28 states have
legalized marijuana for medical use and eight states have enacted laws
regulating it for adult use. We expect that trend to continue regardless of who
the next drug czar is.
"President Trump repeatedly said
he believes states should be able to determine their own marijuana policies,
and the vast majority of Americans agree. We remain hopeful that the
administration will respect state marijuana laws. It is also critical that Congress
take action to ease the tension that exists between state and federal marijuana
laws."
The Marijuana Policy Project is the
nation’s largest marijuana policy organization. For more information, visit http://www.MarijuanaPolicy.org.
Contact
Robert Capecchi, Director of Federal
Policies
651-492-1739, rcapecchi@mpp.org
651-492-1739, rcapecchi@mpp.org
Watch the 420
Cannabis Investor video
More Info:
This news is published on the
Investorideas.com Newswire - a global digital news source for investors and
business leaders
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investment involves risk and possible loss of
investment. This site is currently compensated for news publication and
distribution, social media and marketing, content creation and more. Contact
each company directly regarding content and press release questions. Disclosure
is posted for each compensated news release, content published /created if
required but otherwise the news was not compensated for and was published for
the sole interest of our readers and followers. More disclaimer info: http://www.investorideas.com/About/Disclaimer.asp
Additional info
regarding BC Residents and global Investors: Effective September 15 2008 - all
BC investors should review all OTC and Pink sheet listed companies for
adherence in new disclosure filings and filing appropriate documents with
Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894.
Global investors must adhere to regulations of each country.
No comments:
Post a Comment